GCM
ENFN

Gladius Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Gladius Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69,694
Closed -$661K – 273
2024
Q3 		$661K Buy
69,694
+42,939
+160% +$371K 0.08% 86
2024
Q2 		$228K Buy
+26,755
New +$245K 0.03% 130

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Gladius Capital Management's ENFN Position: Q4 2024 in Review

Gladius Capital Management sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 69,694 shares — an estimated $661K sold.

Gladius Capital Management first reported a position in ENFN in Q2 2024 and held it in 2 quarters. The position peaked at $661K in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • Gladius Capital Management reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 69,694 Enfusion, Inc. shares in Q4 2024, an estimated $661K.
  • Gladius Capital Management first reported a position in Enfusion, Inc. in Q2 2024 and held it in 2 quarters.
  • Gladius Capital Management's Enfusion, Inc. position peaked at $661K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.